Fidelity Investments’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$54.2K Buy
4,913
+2,522
+105% +$27.8K ﹤0.01% 3862
2025
Q1
$21.4K Sell
2,391
-10,085
-81% -$90.1K ﹤0.01% 4204
2024
Q4
$117K Buy
12,476
+10,005
+405% +$94.1K ﹤0.01% 3475
2024
Q3
$19.9K Buy
2,471
+886
+56% +$7.14K ﹤0.01% 4174
2024
Q2
$13.4K Sell
1,585
-585
-27% -$4.96K ﹤0.01% 4217
2024
Q1
$19.5K Sell
2,170
-10,891
-83% -$97.7K ﹤0.01% 4025
2023
Q4
$147K Sell
13,061
-2,840
-18% -$31.9K ﹤0.01% 3056
2023
Q3
$137K Sell
15,901
-948,923
-98% -$8.19M ﹤0.01% 2997
2023
Q2
$9.99M Sell
964,824
-749,565
-44% -$7.76M ﹤0.01% 1865
2023
Q1
$18.6M Sell
1,714,389
-759,083
-31% -$8.24M ﹤0.01% 1633
2022
Q4
$27.8M Sell
2,473,472
-66,815
-3% -$750K ﹤0.01% 1488
2022
Q3
$25.8M Sell
2,540,287
-158,063
-6% -$1.6M ﹤0.01% 1529
2022
Q2
$24.4M Buy
2,698,350
+3,438
+0.1% +$31.1K ﹤0.01% 1573
2022
Q1
$25.8M Buy
2,694,912
+106,531
+4% +$1.02M ﹤0.01% 1672
2021
Q4
$28.6M Sell
2,588,381
-82,500
-3% -$912K ﹤0.01% 1654
2021
Q3
$19.8M Sell
2,670,881
-8,120,982
-75% -$60.1M ﹤0.01% 1851
2021
Q2
$157M Buy
10,791,863
+1,061,697
+11% +$15.4M 0.01% 915
2021
Q1
$199M Buy
9,730,166
+188,372
+2% +$3.84M 0.02% 792
2020
Q4
$170M Buy
9,541,794
+70,172
+0.7% +$1.25M 0.02% 820
2020
Q3
$140M Buy
9,471,622
+64,092
+0.7% +$948K 0.01% 783
2020
Q2
$197M Buy
9,407,530
+42,086
+0.4% +$883K 0.02% 618
2020
Q1
$216M Buy
9,365,444
+906,787
+11% +$21M 0.03% 483
2019
Q4
$219M Buy
8,458,657
+106,383
+1% +$2.75M 0.02% 617
2019
Q3
$163M Buy
8,352,274
+74,979
+0.9% +$1.46M 0.02% 689
2019
Q2
$135M Buy
8,277,295
+82,246
+1% +$1.34M 0.02% 799
2019
Q1
$186M Buy
8,195,049
+25,234
+0.3% +$572K 0.02% 675
2018
Q4
$209M Buy
8,169,815
+46,071
+0.6% +$1.18M 0.03% 577
2018
Q3
$265M Buy
8,123,744
+42,240
+0.5% +$1.38M 0.03% 562
2018
Q2
$183M Buy
8,081,504
+8,493
+0.1% +$193K 0.02% 701
2018
Q1
$196M Buy
8,073,011
+119,527
+2% +$2.9M 0.02% 691
2017
Q4
$222M Buy
7,953,484
+48,586
+0.6% +$1.36M 0.03% 647
2017
Q3
$271M Buy
7,904,898
+59,645
+0.8% +$2.04M 0.03% 566
2017
Q2
$313M Buy
7,845,253
+1,000,823
+15% +$39.9M 0.04% 492
2017
Q1
$252M Buy
6,844,430
+1,276,794
+23% +$47M 0.03% 592
2016
Q4
$177M Buy
5,567,636
+1,537,310
+38% +$49M 0.02% 730
2016
Q3
$146M Buy
4,030,326
+752,111
+23% +$27.3M 0.02% 807
2016
Q2
$74.4M Buy
3,278,215
+1,358,912
+71% +$30.8M 0.01% 1103
2016
Q1
$36.1M Buy
1,919,303
+122,493
+7% +$2.3M 0.01% 1386
2015
Q4
$29.5M Buy
1,796,810
+1,674,391
+1,368% +$27.4M ﹤0.01% 1488
2015
Q3
$1.35M Buy
122,419
+100,049
+447% +$1.1M ﹤0.01% 2486
2015
Q2
$291K Sell
22,370
-2,200
-9% -$28.6K ﹤0.01% 2667
2015
Q1
$426K Hold
24,570
﹤0.01% 2635
2014
Q4
$367K Sell
24,570
-274,378
-92% -$4.1M ﹤0.01% 2684
2014
Q3
$6.89M Sell
298,948
-233,722
-44% -$5.39M ﹤0.01% 2133
2014
Q2
$17M Buy
+532,670
New +$17M ﹤0.01% 1870